Oct 4, 2022

Prof. Dr. Andrea B. Maier, MD, PhD — Building A Clinically Credible Platform For Longevity Medicine

Posted by in categories: biotech/medical, life extension, neuroscience, policy

Building A Clinically Credible Platform For Longevity Medicine — Prof. Dr. Andrea Maier MD, PhD, National University of Singapore, Centre for Healthy Longevity.

Professor Dr. Andrea B. Maier, MD, Ph.D., is the Oon Chiew Seng Professor in Medicine, Healthy Ageing and Dementia Research, and Co-Director of the Centre for Healthy Longevity, at the National University Of Singapore (https://discovery.nus.edu.sg/19564-andrea-britta-maier).

Professor Maier also holds professorship appointments at VU University Medical Centre — https://research.vu.nl/en/persons/andrea-maier, Amsterdam, Netherlands, and University of Melbourne (https://findanexpert.unimelb.edu.au/profile/773728-andrea-maier), Australia, as well as is Director of Medicine and Community Care at the Royal Melbourne Hospital, Australia.

Professor Maier is also the President of the Australia and New Zealand Society for Sarcopenia and Frailty Research, as well as Founding President of the Healthy Longevity Medicine Society — https://hlms.co/.

A Fellow of the Royal Australasian College of Physicians (FRACP), Professor Maier graduated in Medicine (MD) 2003 from the University of Lübeck (Germany), was registered 2009 in The Netherlands as Specialist in Internal Medicine-Geriatrics and was appointed Full Professor of Gerontology at Vrije Universiteit Amsterdam (The Netherlands) in 2013 where she was the head of Geriatrics at the Vrije Universiteit Medical Center from 2012 to 2016.

From 2016 to early 2021, Professor Maier served as Divisional Director of Medicine and Community Care at the Royal Melbourne Hospital, Australia, and as Professor of Medicine and Aged Care at the University of Melbourne, Australia.

Professor Maier’s research focuses on unraveling the mechanisms of ageing and age-related diseases and during the last 10 years she has conducted multiple international observational cohort studies and intervention trials and has published more than 350 peer-reviewed articles. She is a frequent guest on radio and television programs to disseminate aging research and an invited member of several international academic and health policy committees, including the WHO. She also serves as selected Member of The Royal Holland Society of Sciences and Humanities.

Comments are closed.